Market News & Trends
cGMP HEPES, MOPS & MES Available With Full Traceability & Secure Supply Chain
BioSpectra recently announced its cGMP, US-manufactured Zwitterionic Buffers are produced in its new FDA-registered facility in Bangor, PA. These buffers include HEPES, MOPS, and MES,…
Volume Rises, Value Falls for M&A Deals in Global Pharmaceutical & Biotechnology Industry
The challenges posed by expiring patents, the global economic slowdown, and price premium pressures are forcing the pharmaceutical and biotech industry to restructure and streamline…
Volume Rises, Value Falls for M&A Deals in Global Pharmaceutical & Biotechnology Industry
The challenges posed by expiring patents, the global economic slowdown, and price premium pressures are forcing the pharmaceutical and biotech industry to restructure and streamline…
Avantor Appoints New Chief Executive Officer
Avantor Performance Materials recently announced the appointment of Michael Stubblefield as its new Chief Executive Officer. Mr. Stubblefield assumes the role of CEO from Richard…
Horizon Discovery Licenses Gene Editing Technology From ERS Genomics
Horizon Discovery Group plc recently announced it has entered into a non-exclusive license agreement with ERS Genomics Ltd (ERS) to access intellectual property (IP) relating…
Arcadia Biosciences Raises $33 Million
Arcadia Biosciences, Inc. recently announced it has closed on a $33-million round of Series D preferred share equity financing. The round was led with an…
Akorn to Acquire VersaPharm for $440 Million
Akorn, Inc. recently announced it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440 million…
Lundbeck to Acquire Chelsea Therapeutics in $658-Million Deal
H. Lundbeck A/S and Chelsea Therapeutics International, Ltd. recently announced the companies have entered into a definitive agreement under which Lundbeck will acquire Chelsea. Under…
Anokion Secures $37.5 Million, Big Names Invest
Anokion SA recently announced it has successfully closed a Series A financing round for $37.5 million. A group of leading life sciences venture capitalists, consisting…
Regeneron & Avalanche to Develop Next-Generation Gene Therapy Products
Regeneron Pharmaceuticals, Inc. and Avalanche Biotechnologies, Inc. recently announced the formation of a broad collaboration to discover, develop, and commercialize novel gene therapy products for…
Indonesian Pharmaceutical Market Sees Rapid Expansion
Driven by increased government healthcare spending and growing life expectancy, the Indonesian pharmaceutical market value will climb from approximately $5 billion in 2013 to $9.9…
Growth Foreseen at All Levels of the Oral Solid Dosage Form Excipients Market
On a global scale, the oral solid dosage form (OSDF) excipients market is growing sustainably, historically exhibiting a robust increase. This market is valued at…
Novozymes A/S to Build $36-Million Facility, Create 100 R&D Jobs in the US
Novozymes recently announced the establishment of a new R&D center in the US dedicated to its bioagriculture business. The center will be located near the…
Capsugel Enters Agreement With Chiasma
Capsugel recently announced an agreement with Chiasma, Inc., wherein Capsugel’s Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only investigational oral…
Hollow Microstructured Transdermal System Available for Use in Preclinical Studies
3M Drug Delivery Systems Division recently announced the availability of the 3M hollow microstructured transdermal system (hMTS) for pharmaceutical and biotech companies interested in conducting…
Molecular Inhibitor Represents New Treatment Target for Drugs to Halt Atherosclerosis
Working with mice and rabbits, Johns Hopkins scientists have found a way to block abnormal cholesterol production, transport, and breakdown, successfully preventing the development of…
SMARTT e-Patch: A New Electronic Transdermal Patch
Rhenovia Pharma recently announced that its SMARTT e-Patch project has won an award at the World Innovation Challenge founded by the President of France to…
Novozymes' Half-Life Extension Technology Reaches Landmark Milestone Approval
The US FDA has granted marketing approval to GlaxoSmithKline's new type 2 diabetes drug, branded Tanzeum in the US and Eperzan in Europe, which uses…
Emerging Technologies Redefine Infectious Disease Diagnostics
The diagnostics market for infectious diseases, such as tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis C virus, and human papilloma virus is expanding, giving rise…
Big Pharma Seeking to Reduce Risk, Boost Profits Through Strategic Deals
High-priced pharmacy deals are all the rage this year as big drug companies stung by patent expirations attempt to offset losses and reduce risk and…
